In an exclusive interview, the singer discusses his new leading role in 'Cabaret,' the 'American Idol' Season 8 group chat ...
The FDA has proposed ending the use of a common ingredient found in many cold and allergy medicines — and some pharmacies ...
At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine - a common ingredient in many popular ...
An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...
The agreement grants ALK exclusive global rights to the neffy ® adrenaline (epinephrine) nasal spray, with exception of the USA, Australia, New Zealand, Japan and China. The deal delivers on key ...
ALK-Abelló has acquired rights to Neffy adrenaline nasal spray in Europe and Canada, amongst other countries, from ARS ...
ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.